Mylan Inc (NASDAQ:MYL) average recommendation is overweight with average Target Price of $ 48.62. Mylan Inc (NASDAQ:MYL) shares closed at $51.15 on last trade day, by gaining 5.90%. Stock 52 week range is $27.66 – $51.20. Company’s market capitalization is $19.58 billion.
Sagent Pharmaceuticals (NASDAQ:SGNT)‘s stock had its “neutral” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research note issued to investors on Wednesday, Analyst Ratings Net reports. They currently have a $22.00 target price on the stock, down from their previous target price of $24.00. JPMorgan Chase & Co.’s target price would indicate a potential upside of 9.02% from the stock’s previous close. Sagent Pharmaceuticals Inc (NASDAQ:SGNT) stock closed at $22.12 in last trading session, and 52-week range of $0.24 – $0.30. The stock showed a positive weekly performance of 12.11%.
Actavis plc Ordinary Shares(NYSE:ACT) Reports Q4 (Dec) earnings of $3.17 per share, excluding non-recurring items, $0.13 better than the Capital IQ Consensus Estimate of $3.04; revenues rose 58.8% year/year to $2.78 bln vs the $2.66 bln consensus; co raised EPS guidance to modestly above $3.05 on Jan 14. Co reaffirms guidance for FY14 (excluding Forest Labs), sees EPS of $12.60-13.10, excluding non-recurring items, vs. $13.01 Capital IQ Consensus Estimate. Actavis plc Ordinary Shares(NYSE:ACT) stock opened at $205.44 in last trading session and closed at $210.56. The 52 week range of the stock is $82.02 – $213.11 and the day range was $203.59 – $213.11.
Zacks reaffirmed their neutral rating on shares of Zoetis (NYSE:ZTS) in a report issued on Wednesday, American Banking and Market News reports. They currently have a $31.00 target price on the stock. Zoetis Inc (NYSE:ZTS) stock finished the last session at $29.75. The EPS of the stock remained 0.78. Company’s market capitalization is $14.88 billion.